Effects of benfotiamine and coenzyme Q10 on kidney damage induced gentamicin

dc.contributor.authorUstuner, Mehmet Alperen
dc.contributor.authorKaman, Dilara
dc.contributor.authorColakoglu, Neriman
dc.date.accessioned2026-08-12T17:49:21Z
dc.date.issued2017
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: Gentamicin (GM) is an effective antibiotic against severe infection but has limitations related to nephrotoxicity. In this study, we investigated whether benfotiamine (BFT) and coenzyme Q10 (CoQ10), could ameliorate the nephrotoxic effect of GM in rats. Methods: Rats were divided into five groups. Group 1 and 2 served as control and sham respectively, Group 3 as GM group, Group 4 as GM + CoQ10 and Group 5 as GM + BFT for 8 days. At the end of the study, all rats were euthanized by cervical decapitation and then blood samples and kidneys were collected for further analysis. Serum urea, creatinine, cytokine TNF-alpha, oxidant and antioxidant parameters, as well as histopathological examination of kidney tissues were assessed. Results: Gentamicin administration caused a severe nephrotoxicity which was evidenced by an elevated serum creatinine, urea and KIM-1 level as compared with the controls. Moreover, a significant increase in serum malondialdehyde, reduced glutathione. Histopathological examination of renal tissue in gentamisin administered group, there were extremly pronounced necrotic tubules in the renal cortex and hyalen cast accumulation in the medullar tubuli. BFT given to GM rats reduced these nephrotoxicity parameters. Serum creatinine, urea, and KIM-1 were almost normalized in the GM + BFT group. Benfotiamin treatment was significantly decreased necrotic tubuli and hyalen deposition in gentamisin plus benfotiamin group. CoQ10 given to GM rats did not cause any statistically significant alterations in these nephrotoxicity parameters when compared with GM group but histopathological examination of renal tissue in GM + CoQ10 administered group, CoQ10 treatment was decreased necrotic tubuli rate and hyalen accumulation in tubuli. Conclusion: The results from our study indicate that BFT supplement attenuates gentamicin-induced renal injury via the amelioration of oxidative stress and inflammation of renal tubular cells.
dc.identifier.doi10.1016/j.tice.2017.10.001
dc.identifier.endpage696
dc.identifier.issn0040-8166
dc.identifier.issue6
dc.identifier.orcid0000-0001-5583-7586
dc.identifier.pmid29066103
dc.identifier.scopus2-s2.0-85034713590
dc.identifier.scopusqualityQ3
dc.identifier.startpage691
dc.identifier.urihttps://doi.org/10.1016/j.tice.2017.10.001
dc.identifier.urihttps://hdl.handle.net/11508/61759
dc.identifier.volume49
dc.identifier.wosWOS:000417042700008
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherChurchill Livingstone
dc.relation.ispartofTissue & Cell
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBenfotiamine
dc.subjectCoenzyme Q10
dc.subjectNephrotoxicity
dc.subjectOxidative stress
dc.titleEffects of benfotiamine and coenzyme Q10 on kidney damage induced gentamicin
dc.typeArticle

Dosyalar